Hoth Therapeutics, Inc. (HOTH:NASDAQ) jumped higher at $3.35, representing a gain of 78.2%. On Tue, Jun 06, 2023, HOTH:NASDAQ hit a New 2-Week High of $3.35. The stock appeared on our News Catalysts scanner on Tue, Jun 06, 2023 at 08:13 AM in the 'BIOTECH' category. From Tue, May 23, 2023, the stock recorded 55.56% Up Days and 70.00% Green Days
The stock spiked on Tue, Jun 06, 2023 at $4.3 with a volume of 97M+.
About Hoth Therapeutics, Inc. (HOTH:NASDAQ)
Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Top 10 Gainers:
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 78.19%
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 64.67%
- Beamr Imaging Ltd. (BMR:NASDAQ), 49.07%
- eFFECTOR Therapeutics Inc. (EFTR:NASDAQ), 37.62%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 31.46%
- GitLab Inc. (GTLB:NASDAQ), 31.19%
- MicroVision, Inc. (MVIS:NASDAQ), 30.39%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 30.17%
- G-III Apparel Group, Ltd. (GIII:NASDAQ), 28%
- Synlogic, Inc. (SYBX:NASDAQ), 27.46%